About alirocuma b
PCSK9 inhibitor monoclonal antibody
Used for
- Lowers LDL cholesterol in adults with high cholesterol, alongside diet and other treatments.
- Reduces cardiovascular risk in adults with established cardiovascular disease.
Usual adult dose
Usually 75 mg or 150 mg injected under the skin every 2 weeks; some patients use 300 mg every 4 weeks.
Usual dose in children
For familial hypercholesterolemia from age 8: usually 75 mg every 4 weeks, adjusted if needed; follow local product guidance.
Common side effects
- Injection-site reactions
- Flu-like symptoms
- Itching
- Rare allergic reactions
Important warnings
- Seek urgent care for severe allergic reaction, swelling, or trouble breathing.
- Cholesterol levels should be monitored to assess response.
- Not established for children under 8 years.
Pregnancy
Human pregnancy information is limited; use only when clearly needed after medical review.
Breastfeeding
It is unknown whether alirocumab passes into breast milk; discuss treatment with a healthcare professional.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.